Novavax, Inc. (NVAX) financial statements (2022 and earlier)

Company profile

Business Address 21 FIRSTFIELD ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,515 7992157235
Cash and cash equivalents1,515 7970106144
Short-term investments   225191
Restricted cash and investments11 3112830
Receivables455 8  0
Prepaid expense120 4121316
Other current assets53 4456
Total current assets:2,155 97119203288
Noncurrent Assets
Property, plant and equipment229 11283640
Intangible assets, net (including goodwill)136 57596161
Goodwill131 51525452
Intangible assets, net (excluding goodwill)5 6789
Restricted cash and investments  0115
Other noncurrent assets57 7111
Total noncurrent assets:422 768999106
TOTAL ASSETS:2,577 173208302394
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities801 23444035
Accounts payable127 3966
Accrued liabilities674 15203025
Employee-related liabilities   10  
Interest and dividends payable  5555
Deferred revenue1,423 2
Debt131     
Deferred revenue and credits2630
Other liabilities36 1281
Other undisclosed current liabilities   0  
Total current liabilities:2,390 26467466
Noncurrent Liabilities
Long-term debt and lease obligation323 321319318316
Long-term debt, excluding current maturities323 321319318316
Liabilities, other than long-term debt215 1391317
Deferred revenue and credits33
Deferred revenue173 3
Other liabilities42 1091015
Other undisclosed noncurrent liabilities   3  
Total noncurrent liabilities:538 333330331333
Total liabilities:2,928 359376404400
Stockholders' equity
Stockholders' equity attributable to parent(352) (186)(168)(102)(6)
Common stock1 0433
Treasury stock, value(85) (3)(2)(2)(2)
Additional paid in capital3,352 1,2611,1411,020936
Accumulated other comprehensive loss(1) (13)(11)(9)(12)
Accumulated deficit(3,618) (1,432)(1,299)(1,114)(930)
Total stockholders' equity:(352) (186)(168)(102)(6)
TOTAL LIABILITIES AND EQUITY:2,577 173208302394

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues1,146 19343115
Revenue, net312
Gross profit:1,146 19343115
Operating expenses(2,833) (148)(208)(203)(284)
Other undisclosed operating income  9   
Operating loss:(1,687) (121)(174)(172)(269)
Nonoperating income (expense)(7) 1322
Investment income, nonoperating1 2322
Other nonoperating income (expense)(8) (0)00(0)
Interest and debt expense(21) (14)(14)(14)(13)
Loss from continuing operations before income taxes:(1,715) (133)(185)(184)(280)
Income tax expense(29)     
Net loss available to common stockholders, diluted:(1,744) (133)(185)(184)(280)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(1,744) (133)(185)(184)(280)
Comprehensive loss:(1,744) (133)(185)(184)(280)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(8) (1)(3)3(3)
Comprehensive loss, net of tax, attributable to parent:(1,752) (134)(187)(181)(283)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: